POLR3B and Ataxia: Mutations in POLR3B are reported to cause hypomyelinating leukodystrophy type 8 and the clinical presentations of these mutations are widespread and include ataxia, spasticity, variable intellectual disability and epilepsy, and demyelinating sensory motor peripheral neuropathy (Djordjevic et al. 2021).